Literature DB >> 32454721

Phytotherapy as a Complementary Medicine for Multiple Sclerosis.

Zahra Rabiei1.   

Abstract

Multiple sclerosis (MS) is the most common cause of neurologic disability in adults worldwide. Two main issues have caused MS patients to face several problems. One issue is that the definite cause of MS has not yet been determined and the other issue is the lack of a definite treatment for this disease. The people with MS, therefore, seek out complementary and alternative medications to manage the symptoms of this disease. Meanwhile, medicinal plants have been demonstrated to have possible positive pharmacological effects in treating MS in different models. The reliable articles indexed in the databases Web of Science, Scopus, PubMed Central, PubMed, Scientific Information Database, and Institute for Scientific Information were retrieved and analyzed to conduct this review. Medicinal plants and plant compounds caused decreases in the neurologic deficits due to MS. Clinical evidence has demonstrated the clinical potential of Cannabis sativa extract, cannabinoids, Ginkgo biloba, beta-phytosterol, and Lippia citriodora extract to improve MS symptoms. These plants and compounds can also improve spasticity, muscle spasm, neuropathic pain, and urinary tract complications in at least some of these patients. Nanocurcumins and Punica granatum L. peel extract have exhibited positive effects in animal models and can decrease neurologic deficits by reducing inflammation. Medicinal plants and their compounds can serve as new sources of MS drugs because they can improve MS symptoms. ©Copyright 2019 Turk J Pharm Sci, Published by Galenos Publishing House.

Entities:  

Keywords:  medicinal plants; phytotherapy; Multiple sclerosis

Year:  2019        PMID: 32454721      PMCID: PMC7227963          DOI: 10.4274/tjps.galenos.2018.90522

Source DB:  PubMed          Journal:  Turk J Pharm Sci        ISSN: 1304-530X


  38 in total

1.  A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex(®) ), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis.

Authors:  A Novotna; J Mares; S Ratcliffe; I Novakova; M Vachova; O Zapletalova; C Gasperini; C Pozzilli; L Cefaro; G Comi; P Rossi; Z Ambler; Z Stelmasiak; A Erdmann; X Montalban; A Klimek; P Davies
Journal:  Eur J Neurol       Date:  2011-03-01       Impact factor: 6.089

Review 2.  Important role of mast cells in multiple sclerosis.

Authors:  P Conti; D Kempuraj
Journal:  Mult Scler Relat Disord       Date:  2015-11-11       Impact factor: 4.339

3.  Randomized controlled trial of cannabis-based medicine in spasticity caused by multiple sclerosis.

Authors:  C Collin; P Davies; I K Mutiboko; S Ratcliffe
Journal:  Eur J Neurol       Date:  2007-03       Impact factor: 6.089

4.  Neuroprotective effect of pretreatment with Lavandula officinalis ethanolic extract on blood-brain barrier permeability in a rat stroke model.

Authors:  Zahra Rabiei; Mahmoud Rafieian-Kopaei
Journal:  Asian Pac J Trop Med       Date:  2014-09       Impact factor: 1.226

Review 5.  A review of complementary and alternative medicine (CAM) by people with multiple sclerosis.

Authors:  Sherri A Olsen
Journal:  Occup Ther Int       Date:  2009       Impact factor: 1.448

6.  Polymerized nano-curcumin attenuates neurological symptoms in EAE model of multiple sclerosis through down regulation of inflammatory and oxidative processes and enhancing neuroprotection and myelin repair.

Authors:  Maryam Mohajeri; Majid Sadeghizadeh; Farhood Najafi; Mohammad Javan
Journal:  Neuropharmacology       Date:  2015-07-23       Impact factor: 5.250

7.  Beneficial actions of oleanolic acid in an experimental model of multiple sclerosis: a potential therapeutic role.

Authors:  Rubén Martín; Juliana Carvalho-Tavares; Marita Hernández; Mercedes Arnés; Valentina Ruiz-Gutiérrez; María Luisa Nieto
Journal:  Biochem Pharmacol       Date:  2009-08-11       Impact factor: 5.858

8.  Comparison of the immunomodulatory effects of the plant sterol beta-sitosterol to simvastatin in peripheral blood cells from multiple sclerosis patients.

Authors:  Forum Desai; Murali Ramanathan; Carol S Fink; Gregory E Wilding; Bianca Weinstock-Guttman; Atif B Awad
Journal:  Int Immunopharmacol       Date:  2008-11-18       Impact factor: 4.932

9.  Summary of evidence-based guideline: complementary and alternative medicine in multiple sclerosis: report of the guideline development subcommittee of the American Academy of Neurology.

Authors:  Vijayshree Yadav; Christopher Bever; James Bowen; Allen Bowling; Bianca Weinstock-Guttman; Michelle Cameron; Dennis Bourdette; Gary S Gronseth; Pushpa Narayanaswami
Journal:  Neurology       Date:  2014-03-25       Impact factor: 9.910

10.  Loss of 'homeostatic' microglia and patterns of their activation in active multiple sclerosis.

Authors:  Tobias Zrzavy; Simon Hametner; Isabella Wimmer; Oleg Butovsky; Howard L Weiner; Hans Lassmann
Journal:  Brain       Date:  2017-07-01       Impact factor: 13.501

View more
  1 in total

Review 1.  Endocannabinoid Modulation in Neurodegenerative Diseases: In Pursuit of Certainty.

Authors:  Alexandru Vasincu; Răzvan-Nicolae Rusu; Daniela-Carmen Ababei; Mădălina Larion; Walther Bild; Gabriela Dumitrița Stanciu; Carmen Solcan; Veronica Bild
Journal:  Biology (Basel)       Date:  2022-03-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.